• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用Ca2+瞬态图谱的机器学习区分肥厚型心肌病和长QT综合征心脏疾病

Separation of HCM and LQT Cardiac Diseases with Machine Learning of Ca2+ Transient Profiles.

作者信息

Joutsijoki Henry, Penttinen Kirsi, Juhola Martti, Aalto-Setälä Katriina

机构信息

Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, Finland.

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

出版信息

Methods Inf Med. 2019 Nov;58(4-05):167-178. doi: 10.1055/s-0040-1701484. Epub 2020 Feb 20.

DOI:10.1055/s-0040-1701484
PMID:32079026
Abstract

BACKGROUND

Modeling human cardiac diseases with induced pluripotent stem cells not only enables to study disease pathophysiology and develop therapies but also, as we have previously showed, it can offer a tool for disease diagnostics. We previously observed that a few genetic cardiac diseases can be separated from each other and healthy controls by applying machine learning to Ca transient signals measured from iPSC-derived cardiomyocytes (CMs).

OBJECTIVES

For the current research, 419 hypertrophic cardiomyopathy (HCM) transient signals and 228 long QT syndrome (LQTS) transient signals were measured. HCM signals included data recorded from iPSC-CMs carrying either α-tropomyosin, i.e., TPM1 (HCMT) or MYBPC3 or myosin-binding protein C (HCMM) mutation and LQTS signals included data recorded from iPSC-CMs carrying potassium voltage-gated channel subfamily Q member 1 (KCNQ1) mutation (long QT syndrome 1 [LQT1]) or KCNH2 mutation (long QT syndrome 2 [LQT2]). The main objective was to study whether and how effectively HCMM and HCMT can be separated from each other as well as LQT1 from LQT2.

METHODS

After preprocessing those Ca signals where we computed peak waveforms we then classified the two mutations of both disease pairs by using several different machine learning methods.

RESULTS

We obtained excellent classification accuracies of 89% for HCM and even 100% for LQT at their best.

CONCLUSION

The results indicate that the methods applied would be efficient for the identification of these genetic cardiac diseases.

摘要

背景

利用诱导多能干细胞对人类心脏疾病进行建模,不仅能够研究疾病病理生理学并开发治疗方法,而且正如我们之前所展示的,它还可为疾病诊断提供一种工具。我们之前观察到,通过将机器学习应用于从诱导多能干细胞衍生的心肌细胞(CMs)测量的钙瞬变信号,可以将一些遗传性心脏疾病彼此区分开来,并与健康对照区分开。

目的

在当前研究中,测量了419个肥厚型心肌病(HCM)瞬变信号和228个长QT综合征(LQTS)瞬变信号。HCM信号包括从携带α-原肌球蛋白(即TPM1,HCMT)或肌球蛋白结合蛋白C(MYBPC3,HCMM)突变的诱导多能干细胞-心肌细胞记录的数据,LQTS信号包括从携带钾电压门控通道亚家族Q成员1(KCNQ1,长QT综合征1 [LQT1])或KCNH2突变(长QT综合征2 [LQT2])的诱导多能干细胞-心肌细胞记录的数据。主要目的是研究HCMM和HCMT彼此之间以及LQT1和LQT2之间是否以及能在多大程度上有效区分。

方法

在对那些计算了峰值波形的钙信号进行预处理之后,我们使用几种不同的机器学习方法对这两种疾病对的两种突变进行分类。

结果

我们获得了出色的分类准确率,HCM最高可达89%,LQTS甚至可达100%。

结论

结果表明所应用的方法对于识别这些遗传性心脏疾病将是有效的。

相似文献

1
Separation of HCM and LQT Cardiac Diseases with Machine Learning of Ca2+ Transient Profiles.利用Ca2+瞬态图谱的机器学习区分肥厚型心肌病和长QT综合征心脏疾病
Methods Inf Med. 2019 Nov;58(4-05):167-178. doi: 10.1055/s-0040-1701484. Epub 2020 Feb 20.
2
A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.MYBPC3 中的提前终止密码子突变通过非编码介导的衰变的慢性激活导致肥厚型心肌病。
Circulation. 2019 Feb 5;139(6):799-811. doi: 10.1161/CIRCULATIONAHA.118.034624.
3
Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.平板运动试验在长 QT 综合征中的应用及对基因型的预测价值。
Circ Arrhythm Electrophysiol. 2010 Apr;3(2):120-5. doi: 10.1161/CIRCEP.109.907865. Epub 2010 Jan 9.
4
Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.长QT综合征患者伴有KvLQT1和HERG钾通道缺陷时运动应激试验期间的窦房结功能和心室复极
J Am Coll Cardiol. 1999 Sep;34(3):823-9. doi: 10.1016/s0735-1097(99)00255-7.
5
On computational classification of genetic cardiac diseases applying iPSC cardiomyocytes.应用诱导多能干细胞心肌细胞进行遗传性心脏疾病的计算分类。
Comput Methods Programs Biomed. 2021 Oct;210:106367. doi: 10.1016/j.cmpb.2021.106367. Epub 2021 Aug 21.
6
Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy.携带肌球蛋白结合蛋白C或α-原肌球蛋白突变的人诱导多能干细胞衍生心肌细胞中肥厚型心肌病的突变特异性表型
Stem Cells Int. 2016;2016:1684792. doi: 10.1155/2016/1684792. Epub 2015 Dec 28.
7
Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.由一种新型α-原肌球蛋白突变(V95A)引起的肥厚型心肌病与轻度心脏表型、钙与肌钙蛋白结合异常、肌球蛋白循环异常及预后不良相关。
Circulation. 2001 Jan 2;103(1):65-71. doi: 10.1161/01.cir.103.1.65.
8
Detection of genetic cardiac diseases by Ca transient profiles using machine learning methods.利用机器学习方法通过钙瞬变谱检测遗传性心脏疾病。
Sci Rep. 2018 Jun 19;8(1):9355. doi: 10.1038/s41598-018-27695-5.
9
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.年龄和性别对不同基因型长QT综合征临床病程的调节作用。
J Am Coll Cardiol. 2003 Jul 2;42(1):103-9. doi: 10.1016/s0735-1097(03)00554-0.
10
Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy.使用患者来源的诱导多能干细胞进行表型筛选,确定Pyr3为治疗婴儿肥厚型心肌病的候选化合物。
Int Heart J. 2018 Sep 26;59(5):1096-1105. doi: 10.1536/ihj.17-730. Epub 2018 Aug 11.

引用本文的文献

1
Using induced pluripotent stem cells for drug discovery in arrhythmias.利用诱导多能干细胞进行心律失常的药物发现。
Expert Opin Drug Discov. 2024 Jul;19(7):827-840. doi: 10.1080/17460441.2024.2360420. Epub 2024 Jun 2.
2
The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review.在诱导多能干细胞技术中使用人工智能的 10 年历程:系统范围综述。
PLoS One. 2024 May 21;19(5):e0302537. doi: 10.1371/journal.pone.0302537. eCollection 2024.
3
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside.
肥厚型心肌病中的室性心律失常与心源性猝死:从实验台到病床边
Front Cardiovasc Med. 2022 Aug 18;9:949294. doi: 10.3389/fcvm.2022.949294. eCollection 2022.
4
Integrating nonlinear analysis and machine learning for human induced pluripotent stem cell-based drug cardiotoxicity testing.将非线性分析与机器学习整合用于基于人诱导多能干细胞的药物心脏毒性测试。
J Tissue Eng Regen Med. 2022 Aug;16(8):732-743. doi: 10.1002/term.3325. Epub 2022 May 27.
5
Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells.利用人类诱导多能干细胞构建三维心脏结构的生物工程策略
Bioengineering (Basel). 2022 Apr 10;9(4):168. doi: 10.3390/bioengineering9040168.
6
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning.迈向基于人工智能和机器学习的诱导多能干细胞疗法。
Stem Cell Rev Rep. 2022 Feb;18(2):559-569. doi: 10.1007/s12015-021-10302-y. Epub 2021 Nov 29.
7
Machine Learning Techniques to Classify Healthy and Diseased Cardiomyocytes by Contractility Profile.机器学习技术通过收缩性特征对健康和患病心肌细胞进行分类。
ACS Biomater Sci Eng. 2021 Jul 12;7(7):3043-3052. doi: 10.1021/acsbiomaterials.1c00418. Epub 2021 Jun 21.
8
Patient-specific induced pluripotent stem cells as "disease-in-a-dish" models for inherited cardiomyopathies and channelopathies - 15 years of research.患者特异性诱导多能干细胞作为遗传性心肌病和离子通道病的“培养皿中的疾病”模型——15年研究历程
World J Stem Cells. 2021 Apr 26;13(4):281-303. doi: 10.4252/wjsc.v13.i4.281.